SynCore Biotechnology Co Ltd (4192) - Total Liabilities

Latest as of September 2025: NT$14.88 Million TWD ≈ $468.77K USD

Based on the latest financial reports, SynCore Biotechnology Co Ltd (4192) has total liabilities worth NT$14.88 Million TWD (≈ $468.77K USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore SynCore Biotechnology Co Ltd long-term investment allocation to see how much of total assets are deployed in long-term investments.

SynCore Biotechnology Co Ltd - Total Liabilities Trend (2015–2024)

This chart illustrates how SynCore Biotechnology Co Ltd's total liabilities have evolved over time, based on quarterly financial data. For the complete balance sheet picture, see SynCore Biotechnology Co Ltd (4192) total assets.

SynCore Biotechnology Co Ltd Competitors by Total Liabilities

The table below lists competitors of SynCore Biotechnology Co Ltd ranked by their total liabilities.

Company	Country	Total Liabilities
Rapid Synergy Bhd KLSE:7765	Malaysia	RM102.93 Million
Linkhome Holdings Inc. Common stock NASDAQ:LHAI	USA	$1.42 Million
Fabrity Holding S.A. WAR:FAB	Poland	zł13.15 Million
Photon Energy N.V. WAR:PEN	Poland	zł218.56 Million
SyntekaBio Inc KQ:226330	Korea	₩15.35 Billion
Law Debenture Corp LSE:LWDB	UK	GBX191.35 Million
YX Precious Metals Bhd KLSE:0250	Malaysia	RM50.20 Million
CodeMill AB ST:CDMIL	Sweden	Skr22.14 Million

Liability Composition Analysis (2015–2024)

This chart breaks down SynCore Biotechnology Co Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. See SynCore Biotechnology Co Ltd balance sheet independence to measure how much of total assets are equity-financed.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	15.34	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.06	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.05	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how SynCore Biotechnology Co Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for SynCore Biotechnology Co Ltd (2015–2024)

The table below shows the annual total liabilities of SynCore Biotechnology Co Ltd from 2015 to 2024.

Year	Total Liabilities	Change
2024-12-31	NT$23.11 Million ≈ $728.19K	+8.89%
2023-12-31	NT$21.23 Million ≈ $668.74K	-88.69%
2022-12-31	NT$187.64 Million ≈ $5.91 Million	-50.82%
2021-12-31	NT$381.52 Million ≈ $12.02 Million	+7.95%
2020-12-31	NT$353.41 Million ≈ $11.13 Million	+132.75%
2019-12-31	NT$151.84 Million ≈ $4.78 Million	+54.77%
2018-12-31	NT$98.11 Million ≈ $3.09 Million	-21.68%
2017-12-31	NT$125.28 Million ≈ $3.95 Million	-15.61%
2016-12-31	NT$148.46 Million ≈ $4.68 Million	-19.52%
2015-12-31	NT$184.46 Million ≈ $5.81 Million	--

About SynCore Biotechnology Co Ltd

TWO:4192 Taiwan Biotechnology

Market Cap

$20.11 Million

NT$638.24 Million TWD

Market Cap Rank

#25186 Global

#1551 in Taiwan

Share Price

NT$18.15

Change (1 day)

-6.68%

52-Week Range

NT$18.15 - NT$28.30

All Time High

NT$537.12